Nevertheless, DNMT3B seems to play a opposite role in the oncogenesis of leukemia: high expression of DNMT3B contributes to impaired leukemogenesis, and the absence of DNMTB accelerates the progression of MLL-AF9 [42,43]. This evidence concerns the gene DNMT3B and leukemia.